I agree - the Sr Mgt on the ZOOM call made it patently clear that the "toxic note remaining overhang" is small (approx $300K or less) and that Sr Mgt has it as a #1 priority to do a work-out to retire it as soon as possible and is "negotiating other more conventional, less dilutive and stable financing" blah blah.
ALSO - entire OTC has been a shit show to put it mildly - pardon my French. Summer on the OTC is notoriously bad, a wise person telling me "MAY GO AWAY, COME BACK IN SEPTEMBER" is an old "creed to stick by" :)[/b
They're out for more traditional "mezzanine bridge financing" IMO - AND their sales should begin to rapidly grow beginning Aug and that means revenues which also should help move them to a break-even line and off the need to use any financing.
Meaning - they can then self-finance via revenue growth or worst case, get "conventional financing" at attractive terms in these ultra low interest rate times we're living in.
They're "close" folks - a bit more time and let this entire new company and team get the seats warmed and their entire new business plan rolling.
REVENUES and lots of it - will trump ALL OTHER PROBLEMS and they have a damn good plan to RAPIDLY RAMP REVENUES from all I heard on that ZOOM call !!